Samsung Biologics

E72266

Samsung Biologics is a South Korean biopharmaceutical company specializing in contract development and manufacturing (CDMO) of biologic drugs for global pharmaceutical and biotech firms.


Statements (49)

Predicate Object
instanceOf biopharmaceutical company
contract development and manufacturing organization
public company
clientBase emerging biotech firms
multinational pharmaceutical companies
collaboratesWith biotech startups
global pharma partners
country South Korea
focusesOn biologic therapeutics
biosimilars manufacturing support
innovative biologics
foundedBy Samsung
surface form: Samsung Group
hasBusinessArea CMC development services
analytical services
drug product manufacturing
drug substance manufacturing
hasCapability clinical-scale biologics production
commercial-scale biologics production
mammalian cell culture
single-use bioreactor operations
hasFacilityType large-scale biomanufacturing plant
hasKeyBusinessModel fee-for-service CDMO model
outsourced biologics manufacturing
hasOfficialWebsite https://www.samsungbiologics.com
headquartersLocation Incheon NERFINISHED
Songdo International Business District
industry biologics manufacturing
biopharmaceuticals
contract development and manufacturing
languageOfName Korean
locatedInSpecialEconomicZone Incheon Free Economic Zone
offersService end-to-end CDMO services
regulatory support
technology transfer
parentCompany Samsung
surface form: Samsung Group
partOf Samsung healthcare business portfolio
regionServed global
serves global biotechnology companies
global pharmaceutical companies
specializesIn cell line development
contract development of biologic drugs
contract manufacturing of biologic drugs
fill-finish services
monoclonal antibody production
process development
quality control testing
recombinant protein production
stockIndex KOSPI
tradesOn Korea Exchange

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Samsung subsidiary Samsung Biologics